Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 1995; Volume 47,Issue 4
  • You have access
    Recombinant endothelial nitric oxide synthase: post-translational modifications in a baculovirus expression system.
    L Busconi and T Michel
    Molecular Pharmacology April 1995, 47 (4) 655-659;
  • You have access
    Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.
    M A Cascieri, L L Shiao, S G Mills, M MacCoss, C J Swain, H Yu, E Ber, S Sadowski, M T Wu and C D Strader
    Molecular Pharmacology April 1995, 47 (4) 660-665;
  • You have access
    Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization.
    S Pippig, S Andexinger and M J Lohse
    Molecular Pharmacology April 1995, 47 (4) 666-676;
  • You have access
    Regulation of the constitutive expression of the human CYP1A2 gene: cis elements and their interactions with proteins.
    I Chung and E Bresnick
    Molecular Pharmacology April 1995, 47 (4) 677-685;
  • You have access
    Effects of chromium on basal and insulin-induced tyrosine phosphorylation in H4 hepatoma cells: comparison with phorbol-12-myristate-13-acetate and sodium orthovanadate.
    E J Yurkow and G Kim
    Molecular Pharmacology April 1995, 47 (4) 686-695;
  • You have access
    Topoisomerase II alpha promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells.
    D J Fraser, T L Brandt and D J Kroll
    Molecular Pharmacology April 1995, 47 (4) 696-706;
  • You have access
    Comparison of fura-2 imaging and electrophysiological analysis of murine calcium channel alpha 1 subunits coexpressed with novel beta 2 subunit isoforms.
    E Massa, K M Kelly, D I Yule, R L MacDonald and M D Uhler
    Molecular Pharmacology April 1995, 47 (4) 707-716;
  • You have access
    Novel subpopulation of neuronal acetylcholine receptors among those binding alpha-bungarotoxin.
    P C Pugh, R A Corriveau, W G Conroy and D K Berg
    Molecular Pharmacology April 1995, 47 (4) 717-725;
  • You have access
    Adaptive supersensitivity and the Na+/K+ pump in the guinea pig vas deferens: time course of the decline in the alpha 2 subunit.
    K M Hershman, D A Taylor and W W Fleming
    Molecular Pharmacology April 1995, 47 (4) 726-729;
  • You have access
    Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction.
    M L Webb, C C Chao, M Rizzo, R A Shapiro, M Neubauer, E C Liu, C R Aversa, R J Brittain and B Treiger
    Molecular Pharmacology April 1995, 47 (4) 730-737;
  • You have access
    Antibodies to the cloned mu-opioid receptor detect various molecular weight forms in areas of mouse brain.
    J Garzon, J L Juarros, M A Castro and P Sanchez-Blazquez
    Molecular Pharmacology April 1995, 47 (4) 738-744;
  • You have access
    Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase.
    T D Garver, G A Oyler, K A Harris, R Polavarapu, Z Damuni, R A Lehman and M L Billingsley
    Molecular Pharmacology April 1995, 47 (4) 745-756;
  • You have access
    Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds.
    U K Messmer, E G Lapetina and B Brüne
    Molecular Pharmacology April 1995, 47 (4) 757-765;
  • You have access
    Protein-independent lead permeation through myelin lipid liposomes.
    R S Díaz and J Monreal
    Molecular Pharmacology April 1995, 47 (4) 766-771;
  • You have access
    Beta-adrenoceptor-G alpha S coupling decreases with age in rat aorta.
    H Gurdal, E Friedman and M D Johnson
    Molecular Pharmacology April 1995, 47 (4) 772-778;
  • You have access
    Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester.
    J W Boja, J L Cadet, T A Kopajtic, J Lever, H H Seltzman, C D Wyrick, A H Lewin, P Abraham and F I Carroll
    Molecular Pharmacology April 1995, 47 (4) 779-786;
  • You have access
    Mastoparan increases the intracellular free calcium concentration in two insulin-secreting cell lines by inhibition of ATP-sensitive potassium channels.
    G T Eddlestone, M Komatsu, L Shen and G W Sharp
    Molecular Pharmacology April 1995, 47 (4) 787-797;
  • You have access
    Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    S Houssami, D M Findlay, C L Brady, T J Martin, R M Epand, E E Moore, E Murayama, T Tamura, R C Orlowski and P M Sexton
    Molecular Pharmacology April 1995, 47 (4) 798-809;
  • You have access
    Inhibition of human 5-phosphoribosyl-1-pyrophosphate synthetase by 4-amino-8-(beta-D-ribofuranosylamino)-pyrimido[5,4-d]pyrimidine-5'- monophosphate: evidence for interaction at the ADP allosteric site.
    D W Fry, M A Becker and R L Switzer
    Molecular Pharmacology April 1995, 47 (4) 810-815;
  • You have access
    Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    P Aduma, M C Connelly, R V Srinivas and A Fridland
    Molecular Pharmacology April 1995, 47 (4) 816-822;
  • You have access
    Ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) and the tyrphostin ST271 inhibit phospholipase C in human platelets by preventing Ca2+ entry.
    S P Watson, A Poole and J Asselin
    Molecular Pharmacology April 1995, 47 (4) 823-830;
  • You have access
    Novel potent and selective inhibitors of inducible nitric oxide synthase.
    M Nakane, V Klinghofer, J E Kuk, J L Donnelly, G P Budzik, J S Pollock, F Basha and G W Carter
    Molecular Pharmacology April 1995, 47 (4) 831-834;
  • You have access
    Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors.
    R C Tsu, R A Allen and Y H Wong
    Molecular Pharmacology April 1995, 47 (4) 835-841;
  • You have access
    Direct block of calcium channels by dioctanoylglycerol in pregnant rat myometrial cells.
    M Kusaka and N Sperelakis
    Molecular Pharmacology April 1995, 47 (4) 842-847;
  • You have access
    Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    J R Traynor and S R Nahorski
    Molecular Pharmacology April 1995, 47 (4) 848-854;
  • You have access
    Extracellular ATP stimulates adenylyl cyclase and phospholipase C through distinct purinoceptors in NG108-15 cells.
    I Matsuoka, Q Zhou, H Ishimoto and H Nakanishi
    Molecular Pharmacology April 1995, 47 (4) 855-862;
  • You have access
    Unusual carbachol responses in RINm5F cells: evidence for a "distal" site of action in stimulus-secretion coupling.
    S H Tang, G C Yaney and G W Sharp
    Molecular Pharmacology April 1995, 47 (4) 863-870;
  • You have access
    Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    J M Wu, D O Hoang and R I Feldman
    Molecular Pharmacology April 1995, 47 (4) 871-881;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 47, Issue 4
1 Apr 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics